Annovis Announces New Publication in a Peer-Reviewed Journal

Tue, 21 May 2024MALVERN, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neur

Annovis BioMay 20 23:00

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Yahoo FinanceMay 17 10:47

Biocryst Pharmaceuticals, T2 Biosystems, Annovis Bio Among Healthcare Movers

Seeking AlphaMay 15 09:01

Buy Rating Maintained for Annovis Bio Ahead of Key Parkinson's Drug Trial Results

TipRanksMay 15 05:46

10 Health Care Stocks With Whale Alerts In Today's Session

Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

BenzingaMay 14 12:35

Stocks With More Than 10% Short Interest - Finviz Screener

Seeking AlphaMay 13 12:07